Labshake search
Citations for Peprotech :
2051 - 2100 of 2197 citations for 7 nitro 3 oxido 6 4 phenylpiperazin 1 yl 2 1 3 benzoxadiazol 3 ium since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2019Quote: ... and bone morphogenetic protein-2 (BMP2) 300 ng/ml (Peprotech, cat. # 120-02-2UG, Rocky Hill, NJ). The SSC used for differentiation experiments were no older than passage 3 in culture.
-
bioRxiv - Immunology 2022Quote: ... 20 ng/ml (20 units in 200 µl) recombinant murine IL-2 (PeproTECH cat#:212-12-100UG) was added to cultures when indicated ...
-
bioRxiv - Immunology 2022Quote: ... in 96 U-bottomed well plates and in the presence of IL-2 (50 ng/mL; Peprotech). 24h and 48h after stimulation ...
-
bioRxiv - Bioengineering 2024Quote: ... T-cell cultures were supplemented with 200 U/mL IL-2 (Cat # 200-02, Peprotech (Thermo Fisher), Cranbury ...
-
bioRxiv - Cancer Biology 2023Quote: ... viral supernatants were replaced with full RPMI-1640 medium supplemented with 200 U/ml IL-2 (PeproTech) and Dynabeads Human T-Activator CD3/CD28 (Thermo Fisher Scientific).
-
bioRxiv - Neuroscience 2023Quote: ... fibroblasts were cultivated in fibroblast medium supplemented with 2 ng/ml FGF2 (Peprotech, Cat. no. 100-18B). On D3 ...
-
bioRxiv - Cell Biology 2020Quote: ... and resuspended in macrophage complete medium (DMEM/F12, 10% FBS, 1% penicillin/streptomycin, 100 U/ml recombinant murine M-CSF; Peprotech, Rocky Kill, NJ; Cat# 315-02). 5 ml of macrophage complete medium was added on day 3 ...
-
bioRxiv - Bioengineering 2020Quote: ... and resuspended in macrophage complete medium (DMEM/F12, 10% FBS, 1% pen/strep, 100 U/ml recombinant murine M-CSF; Peprotech, Rocky Kill, NJ; Cat# 315-02). 5 ml of macrophage complete medium was added on day 3 ...
-
bioRxiv - Neuroscience 2021Quote: ... Cells were dissociated using 5mM EDTA in HBSS and resuspended in media with B-27 supplement for 4 hours before incubation with recombinant BDNF protein (100nM, Peprotech, #450-02) or vehicle (equal volume of 0.1% BSA in H2O) ...
-
bioRxiv - Immunology 2021Quote: ... Cells were cultured at 1×106 cells/ml in complete RPMI-1640 supplemented with 20 ng/ml GM-CSF and 5 ng/ml IL-4 (PeproTech, Cranbury, NJ) for 7 days (Replaced 70% of medium on Day 2 and Day 5) ...
-
bioRxiv - Immunology 2020Quote: ... Alternately M2 MΦs were activated as follows: M2a MΦs from stimulation with 20 ng/mL recombinant human IL -4 (PeproTech; Rock Hill, NJ, USA) and 25 ng/mL recombinant human IL-13 (PeproTech ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were cultured in the absence of EGF and FGF and with the addition of either 10 ng/mL BMP-4 (Peprotech; #315-27) or 1% or 2% foetal bovine serum (Gibco ...
-
bioRxiv - Immunology 2023Quote: ... in the presence of 40 ng/ml of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4 (both from Peprotech or Biolegend). Cells were cultured in 24-well plates in DMEM (Gibco) ...
-
bioRxiv - Immunology 2019Quote: ... IL-2 (at a final concentration of 200 IU per ml and murine CXCL11 (Peprotech, Rocky Hill, NJ) at a final concentration of 2.7 mg/ml were added to the collagen mixture ...
-
bioRxiv - Immunology 2022Quote: ... cells were allowed to proliferate for two additional days by activation with 50 U/ml IL-2 (Peprotech) and 10% HS and 10% FBS ...
-
bioRxiv - Immunology 2022Quote: ... in T cell medium supplemented with 2ng/ml TGFβ (R&D) and 100 U/ml rhIL-2 (PeproTech) in the presence of plate bound anti-CD3ε (1 μg/mL ...
-
bioRxiv - Genetics 2021Quote: ... T cells were transferred to the culture medium supplemented with 30 IU/mL IL-2 (Peprotech, 200-02A). After electroporation for 3 days ...
-
bioRxiv - Immunology 2021Quote: ... diluted in complete RPMI (cRPMI; RPMI supplemented with 10% FBS plus recombinant human IL-2 (20IU/ml; Peprotech), as previously described.65,66 Activated cells were incubated for six days with a media change on day three.
-
bioRxiv - Immunology 2021Quote: ... in complete RMPI medium supplemented with the recombinant murine 1,000 U/ml IL-2 (PeproTech, Rocky Hill, NJ) and cultured for 5 days ...
-
bioRxiv - Immunology 2021Quote: ... whole bone marrow was plated at 1M cells/mL in cRPMI + 400U/mL Proleukin human IL-2 (Peprotech). Fresh IL-2 was added every 3rd day ...
-
bioRxiv - Immunology 2022Quote: ... and 2 mM glutamine (no BCS) with or without 10 ng/ml TGF-β1 (PeproTech, Rocky Hill, NJ). After 48 hours ...
-
bioRxiv - Developmental Biology 2024Quote: ... Media change on day 0 and 2 were supplemented with 10 ng/ml bFGF (Cat#100-18C, Peprotech). On day 4 ...
-
bioRxiv - Immunology 2023Quote: ... and expanded in RPMI 1640 containing 10% FBS and 100 IU/mL of recombinant human IL-2 (Peprotech). Human blood samples were enriched for T cells using negative bead selection (StemCell ...
-
bioRxiv - Cancer Biology 2024Quote: ... clone OKT3) and anti-CD28 (eBiosciences, clone CD28.2) antibodies in IL-2-containg medium (0.01 ug/ml, Peprotech) for 4 days ...
-
bioRxiv - Molecular Biology 2024Quote: ... 0.2 μg/mL recombinant human relaxin-2 in 0.1% BSA-PBS (Rln, R; Peprotech, Rocky Hill, NJ, USA) and a combination of E+R for the specified amount of time ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 50 ng/mL FGF2 and 30 ng/mL animal-free recombinant human Bone Morphogenic Protein 4 (BMP4, Peprotech, AF-120-05ET) for 24 hours ...
-
bioRxiv - Neuroscience 2021Quote: ... yolk sac embryoid bodies (YS-EBs) were generated by treating EBs with bone morphogenetic protein 4 (BMP4, 50 ng/ml, Peprotech; to induce mesoderm), stem cell factor (SCF ...
-
bioRxiv - Neuroscience 2019Quote: ... the yolk sac embryoid bodies (YS-EBs) were generated by treating the EBs with bone morphogenetic protein 4 (BMP4, 50 ng/ml, Peprotech; to induce mesoderm), vascular endothelial growth factor (VEGF ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated for 4 days with 50 ng/mL of brain-derived growth factor (BDNF) (Peprotech, Rocky Hill, NJ, USA, #450-02B) in serum-depleted EMEM/F12 media supplemented with 1% pen/strep 88,89.
-
bioRxiv - Cell Biology 2021Quote: ... Serum-starved cells were pretreated with 20 nM aPC (Hematologic Technologies, #HCAPC-0080) for 4 h and then incubated with 25 ng/mL TNF-α (PeproTech, #300-01A) for 24 h ...
-
bioRxiv - Genomics 2024Quote: ... For M2 polarization macrophages were cultured in macrophage media supplemented with 20 ng/ml recombinant human IL-4 (PeproTech, catalog no. 200-04). Cells were harvested after 24 ...
-
bioRxiv - Immunology 2024Quote: ... or 6.5 were either left unstimulated or were polarized toward a pro-resolution (‘M2’) or pro-inflammatory phenotype (‘M1’) by addition of 10 ng/mL IL-4 (PeproTech, CAT#214-14) and 10 ng/mL IL-13 (PeproTech ...
-
bioRxiv - Immunology 2023Quote: ... or 12 well plates and treated with 50 ng/mL of IFN-γ (R & D, 485-MI) or 25 ng/mL of IL-4 (PeproTech, 214-14) for 24 hours ...
-
bioRxiv - Biochemistry 2020Quote: ... according to the manufacturer’s instructions and cultured in RPMI supplemented with 10% FBS and 30 U/ml recombinant human IL-2 (PeproTech) at 37°C in 5% CO2 ...
-
bioRxiv - Immunology 2021Quote: ... Two days later cells were passaged and cultured in fresh media supplemented with (12.5U/ml) recombinant IL-2 (PeproTech). Cells were passaged again after 24 hours ...
-
bioRxiv - Cancer Biology 2020Quote: ... cells were treated with 500 U/mL human IFNγ and human IFNβ for 2 days prior to isolation (Peprotech). For all lysate blots ...
-
bioRxiv - Cell Biology 2021Quote: ... These cells were then activated using CD3 and CD28 antibodies in the presence of 100U/ml IL-2 (Peprotech). For reprogramming ...
-
bioRxiv - Biophysics 2022Quote: ... EMT was induced by incubating cells in medium supplemented with 2 ng/mL TGF-β1 (PN:100-21, Peprotech) for 72 hours prior to the measurement ...
-
bioRxiv - Neuroscience 2022Quote: ... coated 6 well plates at 200,000 cells/well in 2 ml/well StemFlex supplemented with ROCK inhibitor Y-27632 (5 mM, PeproTech) to inhibit apoptosis ...
-
bioRxiv - Immunology 2021Quote: ... Switzerland) for 11 days in the human plasma serum-containing medium with 3000 IU/ml of IL-2 (PeproTech). The cell cultures were supplemented with fresh media and IL-2 every 2–4 days ...
-
bioRxiv - Immunology 2021Quote: ... (2) treated with recombinant mouse IL-12 (5 ng/ml) and IL-18 (25 ng/ml, both from Peprotech), (3 ...
-
bioRxiv - Genetics 2022Quote: ... clone 145-2C11, WEHI antibody facility), anti-CD28 (2μg/ml, clone 3751, WEHI antibody facility) and human IL-2 (Peprotech). CD8 T cell cultures contained 25μg/ml anti-mouse IL2 (clone S4B6 ...
-
bioRxiv - Neuroscience 2023Quote: ... the medium was replaced to DMEM/F12 plus 2% B27 with HB-EGF (10 ng/ml, Peprotech, 100-47), EGF (20 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... T cells were removed from Dynabeads rested in T cell media with supplemented 10 U/mL IL-2 (PeproTech) for 48 hours before use ...
-
bioRxiv - Immunology 2023Quote: ... at a density of 7.5×105 cells/ml in 2 ml complete media supplemented with 20 ng/ml recombinant human GM-CSF (Peprotech). The plates were incubated at 37°C in 5% CO2 ...
-
bioRxiv - Immunology 2023Quote: ... seeded at 2 ml per well in 12 well flat-bottom plates and treated with C5a (PeproTech, 300-70) or avacopan for 72 hrs ...
-
bioRxiv - Immunology 2024Quote: CD8 T cells from WT p14 or Irf5-/- p14 mice were isolated as described above and cultured with or without 1µg/ml gp33 peptide in complete RPMI medium supplemented with 2ng/ml recombinant human IL-2 (Peprotech). Cells were then collected at 6 or 24 hours after incubation and washed with PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... in the presence of OVA323–339 peptide (20 μg/ml, Caslo ApS) and IL-2 (5,000 U/ml, Peprotech). As positive control ...
-
bioRxiv - Immunology 2023Quote: ... in the presence of 2mg/mlaCD28 (clone 37.51, WEHI antibody facility) and 100U/ml recombinant human IL-2 (Peprotech), in 96 well flat-bottom plates at 104 cells per well ...
-
bioRxiv - Neuroscience 2024Quote: ... Differentiation of ReN cells was performed by replacing FGF and EGF with 2 ng/ml GDNF (Peprotech, 450–10) and 1 mM dibutyryl-cAMP (Invivochem ...